Marianne de Backer - 03 Apr 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Chief Executive Officer
Signature: /s/ Vanina de Verneuil, Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 03 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2023, 16:53:11 UTC
Previous filing: 11 Jan 2023
Next filing: 26 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Award	$0	+576,452		$0.000000	576,452	03 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Award	$0	+1,152,904		$0.000000	1,152,904	03 Apr 2023	Common Stock	1,152,904	$23.28	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
F2	25% of the shares subject to the stock option vest and become exercisable on April 3, 2024, and the remainder vest in 36 equal monthly installments thereafter.